Answers are grounded in this paper and cite their sources.
This study aimed to assess the impact of an opt-out consent process compared with the opt-in consent process for using pasteurized donor human milk (PDHM) on feeding practices and growth in preterm neonates. A retrospective study of 200 neonates ≤28 weeks' gestation compared the effects of opt-in versus opt-out consent processes on time to first enteral feed, feeding types, growth trajectories, and prematurity-related morbidities. Descriptive statistics were used to compare the two groups. The opt-out process did not significantly alter the time to the first enteral feed (range opt-in: 0–12 days vs. opt-out 0–5 days, Mann–Whitney U; p = 0.295). Compared with the opt-in process, the opt-out process was associated with less formula use, less mother's milk use, and more PDHM/mixed mom's milk-PDHM use in the first 4 weeks of life (p < 0.01). Unadjusted analyses showed a greater weight gain in the opt-out group on days of life/DOLs 14 and 28 (2.49 [0.20, 4.78] and 3.94 [0.07, 7.80]%, p < 0.05), and following adjustment, it remained significant for DOL 14 (1.87 [0.02, 3.71]). Prematurity-related morbidities were similar between the two groups. The opt-out consent process may impart short-term growth benefits in preterm infants. However, long-term outcomes require further study.
No takes yet. Share an insight, caveat, or question.
Cano‐Guerra et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: